Afaxys Pharmaceuticals is pleased to announce the important news that Afaxys and HRA Pharma have joined forces to relaunch ella® (ulipristal acetate) in the U.S.

Afaxys looks forward to supplying the U.S. marketplace with the only FDA-approved emergency contraceptive with the strength to delay ovulation for a full five days, which means extra time for extra prevention. Ella is available by prescription only and is proven safe and effective in clinical trials in over 2,000 women.1

Details related to pricing and product availability dates are still being determined. For additional information please call the ella availability hotline at 843-300-4839. For the most up-to-date information, visit www.afaxys.com. To subscribe to immediate updates on pricing and product availability information, contact sales@afaxys.com.

1Reference: Ella Prescribing Information 2-2014

Important Safety Information

The most common side effects of ella (ulipristal acetate) tablets include headache, stomach pain, nausea, menstrual pain, tiredness, and dizziness. You should not take ella if you know or suspect you are already pregnant, and ella should not replace your regular birth control method. Do not use ella more than one time in the same menstrual cycle. Ella is not for use to end an existing pregnancy. If you become pregnant or have lower stomach pain after taking ella, you should be evaluated for an ectopic pregnancy. Ella may cause your period to be earlier or later than expected. If your period is more than a week late, you should get a pregnancy test. After taking ella, you are likely to be fertile again very quickly, thus, you should continue or start using a regular birth control method as soon as possible to prevent pregnancy. Ella will not protect you against HIV infection (AIDS) and other sexually transmitted disease.

ella Full Prescribing Information